Global Pediatric Vaccines Market Research Report 2026(Status and Outlook)

May 2026 | 164 pages | ID: G6242E89F2B7EN
Bosson Research

Abstracts

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Pediatric Vaccines market size was estimated at USD 34000.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.70% during the forecast period.

This report offers a comprehensive and in-depth analysis of the global Pediatric Vaccines market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.

The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.

A significant focus of this report lies in the competitive landscape of the global Pediatric Vaccines market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.

In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Pediatric Vaccines market.

Global Pediatric Vaccines Market: Market Segmentation Analysis

This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.

A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.

Key Company

• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• AstraZeneca
• Novartis
• Takeda Pharmaceutical
• Bavarian Nordic
• Baxter
• LG Life Sciences
• Lupin
• S K Chemicals
• Mitsubishi Tanabe Pharma
• Janssen
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Bharat Biotech
• Crucell
• Dynavax
• Serum Institute of India

Market Segmentation (by Type)

• Diphtheria
• Influenza
• Hepatitis
• Pneumococcal Diseases
• Meningococcal Diseases
• Others

Market Segmentation (by Application)

• Newborn
• Infant
• Child
• Dolescent

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Pediatric Vaccines Market

Overview of the regional outlook of the Pediatric Vaccines Market:

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pediatric Vaccines Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 shares the main producing countries of Pediatric Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.

Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.

Chapter 13 is the main points and conclusions of the report.

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Pediatric Vaccines
1.2 Key Market Segments
  1.2.1 Pediatric Vaccines Segment by Type
  1.2.2 Pediatric Vaccines Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 PEDIATRIC VACCINES MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Pediatric Vaccines Market Size (M USD) Estimates and Forecasts (2020-2035)
  2.1.2 Global Pediatric Vaccines Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 PEDIATRIC VACCINES MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Pediatric Vaccines Product Life Cycle
3.3 Global Pediatric Vaccines Sales by Manufacturers (2020-2025)
3.4 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2020-2025)
3.5 Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Pediatric Vaccines Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Pediatric Vaccines Market Competitive Situation and Trends
  3.8.1 Pediatric Vaccines Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Pediatric Vaccines Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 PEDIATRIC VACCINES INDUSTRY CHAIN ANALYSIS

4.1 Pediatric Vaccines Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF PEDIATRIC VACCINES MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Pediatric Vaccines Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 U.S. Tariff Policy – April 2025
  5.6.3 Global Trade Frictions and Their Impacts to Pediatric Vaccines Market
5.7 ESG Ratings of Leading Companies

6 PEDIATRIC VACCINES MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pediatric Vaccines Sales Market Share by Type (2020-2025)
6.3 Global Pediatric Vaccines Market Size by Type (2020-2025)
6.4 Global Pediatric Vaccines Price by Type (2020-2025)

7 PEDIATRIC VACCINES MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pediatric Vaccines Market Sales by Application (2020-2025)
7.3 Global Pediatric Vaccines Market Size (M USD) by Application (2020-2025)
7.4 Global Pediatric Vaccines Sales Growth Rate by Application (2020-2025)

8 PEDIATRIC VACCINES MARKET SALES BY REGION

8.1 Global Pediatric Vaccines Sales by Region
  8.1.1 Global Pediatric Vaccines Sales by Region
  8.1.2 Global Pediatric Vaccines Sales Market Share by Region
8.2 Global Pediatric Vaccines Market Size by Region
  8.2.1 Global Pediatric Vaccines Market Size by Region
  8.2.2 Global Pediatric Vaccines Market Size by Region
8.3 North America
  8.3.1 North America Pediatric Vaccines Sales by Country
  8.3.2 North America Pediatric Vaccines Market Size by Country
  8.3.3 U.S. Market Overview
  8.3.4 Canada Market Overview
  8.3.5 Mexico Market Overview
8.4 Europe
  8.4.1 Europe Pediatric Vaccines Sales by Country
  8.4.2 Europe Pediatric Vaccines Market Size by Country
  8.4.3 Germany Market Overview
  8.4.4 France Market Overview
  8.4.5 U.K. Market Overview
  8.4.6 Italy Market Overview
  8.4.7 Spain Market Overview
8.5 Asia Pacific
  8.5.1 Asia Pacific Pediatric Vaccines Sales by Region
  8.5.2 Asia Pacific Pediatric Vaccines Market Size by Region
  8.5.3 China Market Overview
  8.5.4 Japan Market Overview
  8.5.5 South Korea Market Overview
  8.5.6 India Market Overview
  8.5.7 Southeast Asia Market Overview
8.6 South America
  8.6.1 South America Pediatric Vaccines Sales by Country
  8.6.2 South America Pediatric Vaccines Market Size by Country
  8.6.3 Brazil Market Overview
  8.6.4 Argentina Market Overview
  8.6.5 Columbia Market Overview
8.7 Middle East and Africa
  8.7.1 Middle East and Africa Pediatric Vaccines Sales by Region
  8.7.2 Middle East and Africa Pediatric Vaccines Market Size by Region
  8.7.3 Saudi Arabia Market Overview
  8.7.4 UAE Market Overview
  8.7.5 Egypt Market Overview
  8.7.6 Nigeria Market Overview
  8.7.7 South Africa Market Overview

9 PEDIATRIC VACCINES MARKET PRODUCTION BY REGION

9.1 Global Production of Pediatric Vaccines by Region(2020-2025)
9.2 Global Pediatric Vaccines Revenue Market Share by Region (2020-2025)
9.3 Global Pediatric Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Pediatric Vaccines Production
  9.4.1 North America Pediatric Vaccines Production Growth Rate (2020-2025)
  9.4.2 North America Pediatric Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Pediatric Vaccines Production
  9.5.1 Europe Pediatric Vaccines Production Growth Rate (2020-2025)
  9.5.2 Europe Pediatric Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Pediatric Vaccines Production (2020-2025)
  9.6.1 Japan Pediatric Vaccines Production Growth Rate (2020-2025)
  9.6.2 Japan Pediatric Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Pediatric Vaccines Production (2020-2025)
  9.7.1 China Pediatric Vaccines Production Growth Rate (2020-2025)
  9.7.2 China Pediatric Vaccines Production, Revenue, Price and Gross Margin (2020-2025)

10 KEY COMPANIES PROFILE

10.1 GlaxoSmithKline
  10.1.1 GlaxoSmithKline Basic Information
  10.1.2 GlaxoSmithKline Pediatric Vaccines Product Overview
  10.1.3 GlaxoSmithKline Pediatric Vaccines Product Market Performance
  10.1.4 GlaxoSmithKline Business Overview
  10.1.5 GlaxoSmithKline SWOT Analysis
  10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck
  10.2.1 Merck Basic Information
  10.2.2 Merck Pediatric Vaccines Product Overview
  10.2.3 Merck Pediatric Vaccines Product Market Performance
  10.2.4 Merck Business Overview
  10.2.5 Merck SWOT Analysis
  10.2.6 Merck Recent Developments
10.3 Pfizer
  10.3.1 Pfizer Basic Information
  10.3.2 Pfizer Pediatric Vaccines Product Overview
  10.3.3 Pfizer Pediatric Vaccines Product Market Performance
  10.3.4 Pfizer Business Overview
  10.3.5 Pfizer SWOT Analysis
  10.3.6 Pfizer Recent Developments
10.4 Sanofi
  10.4.1 Sanofi Basic Information
  10.4.2 Sanofi Pediatric Vaccines Product Overview
  10.4.3 Sanofi Pediatric Vaccines Product Market Performance
  10.4.4 Sanofi Business Overview
  10.4.5 Sanofi Recent Developments
10.5 AstraZeneca
  10.5.1 AstraZeneca Basic Information
  10.5.2 AstraZeneca Pediatric Vaccines Product Overview
  10.5.3 AstraZeneca Pediatric Vaccines Product Market Performance
  10.5.4 AstraZeneca Business Overview
  10.5.5 AstraZeneca Recent Developments
10.6 Novartis
  10.6.1 Novartis Basic Information
  10.6.2 Novartis Pediatric Vaccines Product Overview
  10.6.3 Novartis Pediatric Vaccines Product Market Performance
  10.6.4 Novartis Business Overview
  10.6.5 Novartis Recent Developments
10.7 Takeda Pharmaceutical
  10.7.1 Takeda Pharmaceutical Basic Information
  10.7.2 Takeda Pharmaceutical Pediatric Vaccines Product Overview
  10.7.3 Takeda Pharmaceutical Pediatric Vaccines Product Market Performance
  10.7.4 Takeda Pharmaceutical Business Overview
  10.7.5 Takeda Pharmaceutical Recent Developments
10.8 Bavarian Nordic
  10.8.1 Bavarian Nordic Basic Information
  10.8.2 Bavarian Nordic Pediatric Vaccines Product Overview
  10.8.3 Bavarian Nordic Pediatric Vaccines Product Market Performance
  10.8.4 Bavarian Nordic Business Overview
  10.8.5 Bavarian Nordic Recent Developments
10.9 Baxter
  10.9.1 Baxter Basic Information
  10.9.2 Baxter Pediatric Vaccines Product Overview
  10.9.3 Baxter Pediatric Vaccines Product Market Performance
  10.9.4 Baxter Business Overview
  10.9.5 Baxter Recent Developments
10.10 LG Life Sciences
  10.10.1 LG Life Sciences Basic Information
  10.10.2 LG Life Sciences Pediatric Vaccines Product Overview
  10.10.3 LG Life Sciences Pediatric Vaccines Product Market Performance
  10.10.4 LG Life Sciences Business Overview
  10.10.5 LG Life Sciences Recent Developments
10.11 Lupin
  10.11.1 Lupin Basic Information
  10.11.2 Lupin Pediatric Vaccines Product Overview
  10.11.3 Lupin Pediatric Vaccines Product Market Performance
  10.11.4 Lupin Business Overview
  10.11.5 Lupin Recent Developments
10.12 S K Chemicals
  10.12.1 S K Chemicals Basic Information
  10.12.2 S K Chemicals Pediatric Vaccines Product Overview
  10.12.3 S K Chemicals Pediatric Vaccines Product Market Performance
  10.12.4 S K Chemicals Business Overview
  10.12.5 S K Chemicals Recent Developments
10.13 Mitsubishi Tanabe Pharma
  10.13.1 Mitsubishi Tanabe Pharma Basic Information
  10.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Overview
  10.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Market Performance
  10.13.4 Mitsubishi Tanabe Pharma Business Overview
  10.13.5 Mitsubishi Tanabe Pharma Recent Developments
10.14 Janssen
  10.14.1 Janssen Basic Information
  10.14.2 Janssen Pediatric Vaccines Product Overview
  10.14.3 Janssen Pediatric Vaccines Product Market Performance
  10.14.4 Janssen Business Overview
  10.14.5 Janssen Recent Developments
10.15 Shenzhen Kangtai Biological Products
  10.15.1 Shenzhen Kangtai Biological Products Basic Information
  10.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Overview
  10.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Market Performance
  10.15.4 Shenzhen Kangtai Biological Products Business Overview
  10.15.5 Shenzhen Kangtai Biological Products Recent Developments
10.16 Sinovac Biotech
  10.16.1 Sinovac Biotech Basic Information
  10.16.2 Sinovac Biotech Pediatric Vaccines Product Overview
  10.16.3 Sinovac Biotech Pediatric Vaccines Product Market Performance
  10.16.4 Sinovac Biotech Business Overview
  10.16.5 Sinovac Biotech Recent Developments
10.17 Bharat Biotech
  10.17.1 Bharat Biotech Basic Information
  10.17.2 Bharat Biotech Pediatric Vaccines Product Overview
  10.17.3 Bharat Biotech Pediatric Vaccines Product Market Performance
  10.17.4 Bharat Biotech Business Overview
  10.17.5 Bharat Biotech Recent Developments
10.18 Crucell
  10.18.1 Crucell Basic Information
  10.18.2 Crucell Pediatric Vaccines Product Overview
  10.18.3 Crucell Pediatric Vaccines Product Market Performance
  10.18.4 Crucell Business Overview
  10.18.5 Crucell Recent Developments
10.19 Dynavax
  10.19.1 Dynavax Basic Information
  10.19.2 Dynavax Pediatric Vaccines Product Overview
  10.19.3 Dynavax Pediatric Vaccines Product Market Performance
  10.19.4 Dynavax Business Overview
  10.19.5 Dynavax Recent Developments
10.20 Serum Institute of India
  10.20.1 Serum Institute of India Basic Information
  10.20.2 Serum Institute of India Pediatric Vaccines Product Overview
  10.20.3 Serum Institute of India Pediatric Vaccines Product Market Performance
  10.20.4 Serum Institute of India Business Overview
  10.20.5 Serum Institute of India Recent Developments

11 PEDIATRIC VACCINES MARKET FORECAST BY REGION

11.1 Global Pediatric Vaccines Market Size Forecast
11.2 Global Pediatric Vaccines Market Forecast by Region
  11.2.1 North America Market Size Forecast by Country
  11.2.2 Europe Pediatric Vaccines Market Size Forecast by Country
  11.2.3 Asia Pacific Pediatric Vaccines Market Size Forecast by Region
  11.2.4 South America Pediatric Vaccines Market Size Forecast by Country
  11.2.5 Middle East and Africa Forecasted Sales of Pediatric Vaccines by Country

12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)

12.1 Global Pediatric Vaccines Market Forecast by Type (2026-2035)
  12.1.1 Global Forecasted Sales of Pediatric Vaccines by Type (2026-2035)
  12.1.2 Global Pediatric Vaccines Market Size Forecast by Type (2026-2035)
  12.1.3 Global Forecasted Price of Pediatric Vaccines by Type (2026-2035)
12.2 Global Pediatric Vaccines Market Forecast by Application (2026-2035)
  12.2.1 Global Pediatric Vaccines Sales (K MT) Forecast by Application
  12.2.2 Global Pediatric Vaccines Market Size (M USD) Forecast by Application (2026-2035)

13 CONCLUSION AND KEY FINDINGS

List Of Tables

LIST OF TABLES

Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Pediatric Vaccines Market Size by Type (M USD)
Table 4. Global Pediatric Vaccines Market Size by Application
Table 5. Pediatric Vaccines Market Size Comparison by Region (M USD)
Table 6. Global Pediatric Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Pediatric Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Pediatric Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Pediatric Vaccines Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2025)
Table 11. Global Market Pediatric Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pediatric Vaccines Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Pediatric Vaccines Sales by Type (K MT)
Table 27. Global Pediatric Vaccines Market Size by Type (M USD)
Table 28. Global Pediatric Vaccines Sales (K MT) by Type (2020-2025)
Table 29. Global Pediatric Vaccines Sales Market Share by Type (2020-2025)
Table 30. Global Pediatric Vaccines Market Size (M USD) by Type (2020-2025)
Table 31. Global Pediatric Vaccines Market Share by Type (2020-2025)
Table 32. Global Pediatric Vaccines Price (USD/KG) by Type (2020-2025)
Table 33. Global Pediatric Vaccines Sales (K MT) by Application
Table 34. Global Pediatric Vaccines Market Size by Application
Table 35. Global Pediatric Vaccines Sales by Application (2020-2025) & (K MT)
Table 36. Global Pediatric Vaccines Sales Market Share by Application (2020-2025)
Table 37. Global Pediatric Vaccines Market Size by Application (2020-2025) & (M USD)
Table 38. Global Pediatric Vaccines Market Share by Application (2020-2025)
Table 39. Global Pediatric Vaccines Sales Growth Rate by Application (2020-2025)
Table 40. Global Pediatric Vaccines Sales by Region (2020-2025) & (K MT)
Table 41. Global Pediatric Vaccines Sales Market Share by Region (2020-2025)
Table 42. Global Pediatric Vaccines Market Size by Region (2020-2025) & (M USD)
Table 43. Global Pediatric Vaccines Market Size by Region (2020-2025)
Table 44. North America Pediatric Vaccines Sales by Country (2020-2025) & (K MT)
Table 45. North America Pediatric Vaccines Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Pediatric Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. Europe Pediatric Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Pediatric Vaccines Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Pediatric Vaccines Market Size by Region (2020-2025) & (M USD)
Table 50. South America Pediatric Vaccines Sales by Country (2020-2025) & (K MT)
Table 51. South America Pediatric Vaccines Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Pediatric Vaccines Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Pediatric Vaccines Market Size by Region (2020-2025) & (M USD)
Table 54. Global Pediatric Vaccines Production (K MT) by Region(2020-2025)
Table 55. Global Pediatric Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Pediatric Vaccines Revenue Market Share by Region (2020-2025)
Table 57. Global Pediatric Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Pediatric Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Pediatric Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Pediatric Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Pediatric Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Pediatric Vaccines Product Overview
Table 64. GlaxoSmithKline Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Merck Basic Information
Table 69. Merck Pediatric Vaccines Product Overview
Table 70. Merck Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Merck Business Overview
Table 72. Merck SWOT Analysis
Table 73. Merck Recent Developments
Table 74. Pfizer Basic Information
Table 75. Pfizer Pediatric Vaccines Product Overview
Table 76. Pfizer Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pfizer Business Overview
Table 78. Pfizer SWOT Analysis
Table 79. Pfizer Recent Developments
Table 80. Sanofi Basic Information
Table 81. Sanofi Pediatric Vaccines Product Overview
Table 82. Sanofi Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Sanofi Business Overview
Table 84. Sanofi Recent Developments
Table 85. AstraZeneca Basic Information
Table 86. AstraZeneca Pediatric Vaccines Product Overview
Table 87. AstraZeneca Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Recent Developments
Table 90. Novartis Basic Information
Table 91. Novartis Pediatric Vaccines Product Overview
Table 92. Novartis Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Novartis Business Overview
Table 94. Novartis Recent Developments
Table 95. Takeda Pharmaceutical Basic Information
Table 96. Takeda Pharmaceutical Pediatric Vaccines Product Overview
Table 97. Takeda Pharmaceutical Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Takeda Pharmaceutical Business Overview
Table 99. Takeda Pharmaceutical Recent Developments
Table 100. Bavarian Nordic Basic Information
Table 101. Bavarian Nordic Pediatric Vaccines Product Overview
Table 102. Bavarian Nordic Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bavarian Nordic Business Overview
Table 104. Bavarian Nordic Recent Developments
Table 105. Baxter Basic Information
Table 106. Baxter Pediatric Vaccines Product Overview
Table 107. Baxter Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Baxter Business Overview
Table 109. Baxter Recent Developments
Table 110. LG Life Sciences Basic Information
Table 111. LG Life Sciences Pediatric Vaccines Product Overview
Table 112. LG Life Sciences Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. LG Life Sciences Business Overview
Table 114. LG Life Sciences Recent Developments
Table 115. Lupin Basic Information
Table 116. Lupin Pediatric Vaccines Product Overview
Table 117. Lupin Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Lupin Business Overview
Table 119. Lupin Recent Developments
Table 120. S K Chemicals Basic Information
Table 121. S K Chemicals Pediatric Vaccines Product Overview
Table 122. S K Chemicals Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. S K Chemicals Business Overview
Table 124. S K Chemicals Recent Developments
Table 125. Mitsubishi Tanabe Pharma Basic Information
Table 126. Mitsubishi Tanabe Pharma Pediatric Vaccines Product Overview
Table 127. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Mitsubishi Tanabe Pharma Business Overview
Table 129. Mitsubishi Tanabe Pharma Recent Developments
Table 130. Janssen Basic Information
Table 131. Janssen Pediatric Vaccines Product Overview
Table 132. Janssen Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Janssen Business Overview
Table 134. Janssen Recent Developments
Table 135. Shenzhen Kangtai Biological Products Basic Information
Table 136. Shenzhen Kangtai Biological Products Pediatric Vaccines Product Overview
Table 137. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 138. Shenzhen Kangtai Biological Products Business Overview
Table 139. Shenzhen Kangtai Biological Products Recent Developments
Table 140. Sinovac Biotech Basic Information
Table 141. Sinovac Biotech Pediatric Vaccines Product Overview
Table 142. Sinovac Biotech Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 143. Sinovac Biotech Business Overview
Table 144. Sinovac Biotech Recent Developments
Table 145. Bharat Biotech Basic Information
Table 146. Bharat Biotech Pediatric Vaccines Product Overview
Table 147. Bharat Biotech Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 148. Bharat Biotech Business Overview
Table 149. Bharat Biotech Recent Developments
Table 150. Crucell Basic Information
Table 151. Crucell Pediatric Vaccines Product Overview
Table 152. Crucell Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 153. Crucell Business Overview
Table 154. Crucell Recent Developments
Table 155. Dynavax Basic Information
Table 156. Dynavax Pediatric Vaccines Product Overview
Table 157. Dynavax Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 158. Dynavax Business Overview
Table 159. Dynavax Recent Developments
Table 160. Serum Institute of India Basic Information
Table 161. Serum Institute of India Pediatric Vaccines Product Overview
Table 162. Serum Institute of India Pediatric Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 163. Serum Institute of India Business Overview
Table 164. Serum Institute of India Recent Developments
Table 165. Global Pediatric Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 166. Global Pediatric Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 167. North America Pediatric Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 168. North America Pediatric Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 169. Europe Pediatric Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 170. Europe Pediatric Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 171. Asia Pacific Pediatric Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 172. Asia Pacific Pediatric Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 173. South America Pediatric Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 174. South America Pediatric Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 175. Middle East and Africa Pediatric Vaccines Sales Forecast by Country (2026-2035) & (Units)
Table 176. Middle East and Africa Pediatric Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 177. Global Pediatric Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 178. Global Pediatric Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 179. Global Pediatric Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 180. Global Pediatric Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 181. Global Pediatric Vaccines Market Size Forecast by Application (2026-2035) & (M USD)

List Of Figures

LIST OF FIGURES

Figure 1. Product Picture of Pediatric Vaccines
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pediatric Vaccines Market Size (M USD), 2025-2035
Figure 5. Global Pediatric Vaccines Market Size (M USD) (2020-2035)
Figure 6. Global Pediatric Vaccines Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pediatric Vaccines Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Pediatric Vaccines Product Life Cycle
Figure 13. Pediatric Vaccines Sales Share by Manufacturers in 2025
Figure 14. Global Pediatric Vaccines Revenue Share by Manufacturers in 2025
Figure 15. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Pediatric Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Pediatric Vaccines Revenue in 2025
Figure 18. Industry Chain Map of Pediatric Vaccines
Figure 19. Global Pediatric Vaccines Market PEST Analysis
Figure 20. Global Pediatric Vaccines Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Pediatric Vaccines Market Share by Type
Figure 27. Sales Market Share of Pediatric Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Pediatric Vaccines by Type in 2025
Figure 29. Market Share of Pediatric Vaccines by Type (2020-2025)
Figure 30. Market Share of Pediatric Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Pediatric Vaccines Market Share by Application
Figure 33. Global Pediatric Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Pediatric Vaccines Sales Market Share by Application in 2025
Figure 35. Global Pediatric Vaccines Market Share by Application (2020-2025)
Figure 36. Global Pediatric Vaccines Market Share by Application in 2025
Figure 37. Global Pediatric Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Pediatric Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Pediatric Vaccines Market Size by Region (2020-2025)
Figure 40. North America Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Pediatric Vaccines Sales Market Share by Country in 2024
Figure 43. North America Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Pediatric Vaccines Market Size by Country in 2024
Figure 45. U.S. Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Pediatric Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Pediatric Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Pediatric Vaccines Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Pediatric Vaccines Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Pediatric Vaccines Sales Market Share by Country in 2024
Figure 53. Europe Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Pediatric Vaccines Market Size by Country in 2024
Figure 55. Germany Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Pediatric Vaccines Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Pediatric Vaccines Sales Market Share by Region in 2024
Figure 67. Asia Pacific Pediatric Vaccines Market Size by Region in 2024
Figure 68. China Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Pediatric Vaccines Sales and Growth Rate (K MT)
Figure 79. South America Pediatric Vaccines Sales Market Share by Country in 2024
Figure 80. South America Pediatric Vaccines Market Size and Growth Rate (M USD)
Figure 81. South America Pediatric Vaccines Market Size by Country in 2024
Figure 82. Brazil Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Pediatric Vaccines Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Pediatric Vaccines Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Pediatric Vaccines Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Pediatric Vaccines Market Size by Region in 2024
Figure 92. Saudi Arabia Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Pediatric Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Pediatric Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Pediatric Vaccines Production Market Share by Region (2020-2025)
Figure 103. North America Pediatric Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Pediatric Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Pediatric Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. China Pediatric Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Pediatric Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Pediatric Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Pediatric Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Pediatric Vaccines Market Share Forecast by Type (2026-2035)
Figure 111. Global Pediatric Vaccines Sales Forecast by Application (2026-2035)
Figure 112. Global Pediatric Vaccines Market Share Forecast by Application (2026-2035)